Published in Int J Hypertens on September 22, 2011
Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (2001) 8.53
G protein-coupled receptor kinases. Annu Rev Biochem (1998) 5.53
Seven-transmembrane-spanning receptors and heart function. Nature (2002) 5.38
Structure and function of an irreversible agonist-β(2) adrenoceptor complex. Nature (2011) 5.35
Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature (1997) 5.31
Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol (1999) 4.70
beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science (1990) 4.53
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation (1993) 4.52
The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol (1998) 3.87
G protein beta gamma subunits. Annu Rev Pharmacol Toxicol (1997) 3.50
Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem (1995) 3.45
Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem (2002) 3.40
Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Natl Acad Sci U S A (1986) 3.38
AKAPs: from structure to function. Trends Cell Biol (1999) 3.15
Vascular adrenoceptors: an update. Pharmacol Rev (2001) 2.83
Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol (1996) 2.70
Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. Circ Res (1999) 2.37
Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem (1999) 2.28
AKAP mediated signal transduction. Annu Rev Pharmacol Toxicol (2002) 2.26
Seven transmembrane receptors: something old, something new. Acta Physiol (Oxf) (2007) 2.25
Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr Opin Cell Biol (2001) 2.23
G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Invest (1997) 2.16
Ion channels and vascular tone. Hypertension (2000) 2.14
Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J Biol Chem (1989) 2.10
Beta-receptor activity in aorta; variations with age and species. Circ Res (1970) 2.06
RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking. Science (2001) 2.05
Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. J Biol Chem (1999) 1.97
Membrane organization in G-protein mechanisms. FASEB J (1994) 1.93
Imaging nanometer domains of beta-adrenergic receptor complexes on the surface of cardiac myocytes. Nat Chem Biol (2005) 1.88
Phosphorylation and desensitization of the human beta 1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. J Biol Chem (1995) 1.88
Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase. Am J Physiol Renal Physiol (2000) 1.77
Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest (2001) 1.71
A region of adenylyl cyclase 2 critical for regulation by G protein beta gamma subunits. Science (1995) 1.70
Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Sci STKE (2001) 1.70
Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels. Med Clin North Am (2009) 1.59
Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem (2002) 1.59
Recent advances in cardiac beta(2)-adrenergic signal transduction. Circ Res (1999) 1.49
Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem (1999) 1.42
Structural insights into adrenergic receptor function and pharmacology. Trends Pharmacol Sci (2011) 1.42
Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. Proc Natl Acad Sci U S A (1993) 1.41
Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol (2002) 1.38
Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol Pharmacol (2002) 1.37
Structure, mechanism, and regulation of mammalian adenylyl cyclase. J Biol Chem (1999) 1.36
Functional receptor coupling to Gi is a mechanism of agonist-promoted desensitization of the beta2-adrenergic receptor. J Recept Signal Transduct Res (2000) 1.35
Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor. J Biol Chem (1996) 1.32
Endothelial dysfunction and aging: an update. Ageing Res Rev (2009) 1.31
The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol (2010) 1.30
Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol (1999) 1.26
Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol (2000) 1.23
Further studies on the effect of ageing on beta-adrenoceptor activity of rat aorta. Br J Pharmacol (1971) 1.21
Phosphorylation and activation of beta-adrenergic receptor kinase by protein kinase C. J Biol Chem (1995) 1.18
Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. Atherosclerosis (2006) 1.17
Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. Circ Res (2005) 1.17
Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol (2010) 1.13
Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization. Proc Natl Acad Sci U S A (1994) 1.10
Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A. Am J Physiol Cell Physiol (2001) 1.08
β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. J Cardiovasc Pharmacol (2010) 1.08
Compartmentation of cyclic adenosine 3',5'-monophosphate signaling in caveolae. Mol Endocrinol (1999) 1.06
Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats. J Pharmacol Exp Ther (1998) 1.05
Protein kinase cross-talk: membrane targeting of the beta-adrenergic receptor kinase by protein kinase C. Proc Natl Acad Sci U S A (1996) 1.01
Colocalization of beta-adrenergic receptors and caveolin within the plasma membrane. J Cell Biochem (1999) 0.99
Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta. Br J Pharmacol (2000) 0.99
Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology (1998) 0.98
Vascular endothelial ageing, heartbeat after heartbeat. Cardiovasc Res (2009) 0.97
Angiotensin II and phorbol ester enhance isoproterenol- and vasoactive intestinal peptide (VIP)-induced cyclic AMP accumulation in vascular smooth muscle cells. Biochem Biophys Res Commun (1985) 0.94
Characterization of beta-adrenergic receptors in cultured human and bovine endothelial cells. J Appl Physiol (1985) (1988) 0.93
Altered beta-adrenergic receptor-stimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors. J Biol Chem (1993) 0.92
Regulation of vascular smooth muscle tone. Can J Physiol Pharmacol (1994) 0.91
Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications. Ageing Res Rev (2003) 0.89
Downregulation of caveolin by chronic beta-adrenergic receptor stimulation in mice. Am J Physiol (1997) 0.89
Endothelial adrenoceptors. J Cardiovasc Pharmacol (2001) 0.89
Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. Adv Pharmacol (2010) 0.88
Changes in caveolin subtype protein expression in aging rat organs. Mol Cell Endocrinol (2001) 0.87
Adrenergic mechanisms in blood vessels: morphological and pharmacological aspects. Rev Physiol Biochem Pharmacol (1983) 0.86
Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells. Am J Physiol (1997) 0.85
Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications. J Cardiovasc Transl Res (2010) 0.85
Impaired isoproterenol-induced hyperpolarization in isolated mesenteric arteries of aged rats. Hypertension (1999) 0.85
Vascular smooth muscle. A review of the molecular basis of contractility. Circulation (1991) 0.84
Binding of purified recombinant beta-arrestin to guanine-nucleotide-binding-protein-coupled receptors. Eur J Biochem (1995) 0.84
The influence of animal age on beta-adrenoceptor density and function in tracheal airway smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.82
Angiotensin II enhancement of hormone-stimulated cAMP formation in cultured vascular smooth muscle cells. Am J Physiol (1993) 0.81
Role of cyclic AMP-dependent protein kinase in the diminished beta adrenergic responsiveness of vascular smooth muscle with increasing age. J Pharmacol Exp Ther (1989) 0.81
Upregulation of G protein-linked receptor kinases with advancing age in rat aorta. Am J Physiol Regul Integr Comp Physiol (2001) 0.81
Endogenous nitric oxide attenuates beta-adrenoceptor-mediated relaxation in rat aorta. Clin Exp Pharmacol Physiol (2007) 0.80
Decreased beta-adrenoceptor-mediated vasodilation in aorta from aged rats: possible involvement of a stimulatory GTP-binding protein. Eur J Pharmacol (1991) 0.80
Multiple scaffolding functions of {beta}-arrestins in the degradation of G protein-coupled receptor kinase 2. J Biol Chem (2010) 0.80
The function of vascular smooth muscle phosphodiesterase III is preserved in healthy human aging. Clin Transl Sci (2010) 0.79
Effect of maturation and aging on beta-adrenergic signal transduction in rat kidney and liver. Biochem Pharmacol (2000) 0.79
Vascular beta-adrenergic receptor adenylyl cyclase system in maturation and aging. J Mol Cell Cardiol (2000) 0.79
Relationships between beta- and alpha2-adrenoceptors and G coupling proteins in the human brain: effects of age and suicide. Brain Res (2001) 0.78
Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle. Am J Physiol Heart Circ Physiol (2004) 0.78
Age-related changes in G proteins in rat aorta. J Gerontol A Biol Sci Med Sci (1996) 0.78
Vascular beta-adrenoceptor-mediated relaxation and the tone of the tissue in canine arteries. J Pharm Pharmacol (1995) 0.78
Age-related differences in cyclic AMP metabolism and their consequences on relaxation induced by isoproterenol and phosphodiesterase inhibitors in rat isolated aorta. Mech Ageing Dev (1990) 0.78
Characterization of clonal vascular smooth muscle cell lines derived from young and old Fischer 344 rats. In Vitro Cell Dev Biol Anim (2011) 0.78
Age-related involvement of the endothelium in beta-adrenoceptor-mediated relaxation of rat aorta. Eur J Pharmacol (2000) 0.77
Arterial compliance in the elderly: its effect on blood pressure measurement and cardiovascular outcomes. Clin Geriatr Med (2009) 0.77
Effect of age on vascular beta2-adrenergic receptor desensitization is not mediated by the receptor coupling to Galphai proteins. J Gerontol A Biol Sci Med Sci (2006) 0.77
Angiotensin II potentiates vasodilation of rat aorta by cAMP elevating agonists. J Pharmacol Exp Ther (1997) 0.77
Angiotensin II enhances beta-adrenergic receptor-mediated vasorelaxation in aortas from young but not old rats. Am J Physiol Heart Circ Physiol (2000) 0.77
Hospital at home: feasibility and outcomes of a program to provide hospital-level care at home for acutely ill older patients. Ann Intern Med (2005) 2.58
Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney. Diabetes (2006) 1.22
Comparison of functional outcomes associated with hospital at home care and traditional acute hospital care. J Am Geriatr Soc (2008) 0.94
Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications. Ageing Res Rev (2003) 0.89
Health care provider evaluation of a substitutive model of hospital at home. Med Care (2009) 0.80
Age-related β-adrenergic receptor-mediated vasorelaxation is changed by altering G protein receptor kinase 2 expression. Vascul Pharmacol (2011) 0.80
Comparison of stress experienced by family members of patients treated in hospital at home with that of those receiving traditional acute hospital care. J Am Geriatr Soc (2007) 0.79
Characterization of clonal vascular smooth muscle cell lines derived from young and old Fischer 344 rats. In Vitro Cell Dev Biol Anim (2011) 0.78
Decline in caveolin-1 expression and scaffolding of G protein receptor kinase-2 with age in Fischer 344 aortic vascular smooth muscle. Am J Physiol Heart Circ Physiol (2004) 0.78
Effect of age on vascular beta2-adrenergic receptor desensitization is not mediated by the receptor coupling to Galphai proteins. J Gerontol A Biol Sci Med Sci (2006) 0.77